Publications by authors named "Firas Rahhal"

Claim this Profile
O
ONS-5010 (bevacizumab-vikg) Safety and Efficacy in Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration.
Firas M Rahhal, Allen Hu, Mark Humayun, Meena S George, Cameron Javid

Ophthalmic Surg Lasers Imaging Retina· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Follow-up of a Phase 1/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic Atrophy.
Mark S Humayun, Dennis O Clegg, Margot S Dayan, Amir H Kashani, Firas M Rahhal

Ophthalmology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes of the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema.
Christine Morozova, Lucas L Humayun, Jonathan Kasper, Andy Morozov, Homayoun Tabandeh, Firas M Rahhal

J Vitreoretin Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degeneration.
Amir H Kashani, Jane S Lebkowski, David R Hinton, Danhong Zhu, Mohamed A Faynus, Firas M Rahhal

Stem Cell Reports· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular Degeneration.
Amir H Kashani, Jane S Lebkowski, Firas M Rahhal, Robert L Avery, Hani Salehi-Had

Transl Vis Sci Technol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Method for Implantation of a Biosynthetic Retinal Pigment Epithelium Monolayer for Geographic Atrophy: Experience from a Phase 1/2a Study.
Amir H Kashani, Jeremy Uang, Melissa Mert, Firas Rahhal, Clement Chan

Ophthalmol Retina· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary outcomes of the VIDI study: phase 2, double-masked, randomized, active-controlled study of ASP8232 for diabetic macular edema.
Quan Dong Nguyen, Yasir J Sepah, Brian Berger, David Brown, Diana V Do, Firas M Rahhal

Int J Retina Vitreous· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration.
Amir H Kashani, Jane S Lebkowski, Firas M Rahhal, Robert L Avery, Hani Salehi-Had

Sci Transl Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Congenital optic nerve anomaly and migration of subretinal oil: case report and observations in one family.
Michelle V Carle, Michael C Rahhal, Firas M Rahhal

Retin Cases Brief Rep· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials.
Gui-shuang Ying, Benjamin J Kim, Maureen G Maguire, Jiayan Huang, Ebenezer Daniel, Firas Rahhal

JAMA Ophthalmol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Travel to high mountain elevations following vitrectomy with intraocular gas.
Steve D Levasseur, Firas M Rahhal

Retina· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis